Commercial & Medical Affairs - software & AI news

Daily news on software, AI, and companies shaping commercial & medical affairs.

Showing 82 results
An office desk with a financial report and calculator in natural light.

Aug 29, 2026

Veeva: Operating Income Jumps 40% As Vault CRM And AI Adoption Accelerate

Veeva Systems has reported a significant increase in operating income, driven by the growing adoption of its Vault CRM and AI solutions, leading to an optimistic outlook for fiscal 2027.In its fiscal second quarter of 2027, Veeva achieved an 18% year-over-year revenue growth, totaling $928 million. Notably, subscription revenue, which constitutes a major portion of its business, rose by 16% to $766.8 million. The company experienced a remarkable 40% increase in GAAP operating income, reaching $2
A calculator on an office desk with financial documents in a dimly lit setting.

Aug 29, 2026

Veeva: Operating Income Jumps 40% As Vault CRM And AI Adoption Accelerate

Veeva Systems has reported a notable increase in operating income, driven by the expansion of its Vault CRM and advancements in AI technology.In the fiscal second quarter of 2027, Veeva experienced an 18% year-over-year revenue growth, reaching $928 million, with subscription revenue making up the majority at $766.8 million. The company saw its GAAP operating income surge by 40% to $275 million, significantly outpacing revenue growth and indicating strong operational efficiency. Non-GAAP metrics
Minimalist illustration of a pill and tablet on a dark background

Aug 28, 2026

Veeva: Operating Income Jumps 40% As Vault CRM And AI Adoption Accelerate

Veeva Systems has reported a significant increase in operating income, fueled by the accelerating adoption of its Vault CRM and AI solutions within the life sciences sector.In its fiscal second quarter of 2027, Veeva experienced an 18% increase in total revenue, reaching $928 million. Subscription revenue, a key component of its business model, rose 16% to $766.8 million, highlighting the company's strong recurring revenue stream. Operating income saw a remarkable 40% jump to $275 million, indic
Press release cover image

Aug 26, 2026

PharmaForceIQ Launches Optichannel 360, the First AI-Native Answer-to-Action Engine for Pharma Commercial Teams

MIAMI, Aug. 26, 2026 /PRNewswire/ -- PharmaForceIQ has today introduced Optichannel 360, an AI-native commercial execution platform that connects field and digital marketing, including a new measurement answer-to-action workflow. The Optichannel 360 platform is built as a broader commercial operating layer for pharma teams, with a closed loop model that already connects strategy, systems, workflows, measurement, decisioning, and execution across field and digital channels. Its first packaged cap
Press release cover image

Aug 25, 2026

Lundbeck and EVERSANA Announce Strategic Partnership to Advance AI-Powered Commercialization

Collaboration expands deployment of EVERSANA's AI Agency platform and commercialization capabilities to advance Lundbeck's Focused Innovator strategy and bionic ambitions CHICAGO and DEERFIELD, Ill., Aug. 25, 2026 /PRNewswire/ -- Lundbeck, a global pharmaceutical company focused exclusively on brain health, and EVERSANA®, a leading global provider of commercial services to the life sciences industry, today announced a strategic partnership to advance AI-powered commercialization across Lundbeck'
A minimalist illustration of a pill surrounded by a data stream, symbolizing AI in life sciences.

Aug 21, 2026

EVERSANA grows AI platform for life sciences

EVERSANA is enhancing its AI commercialization platform by integrating new medical affairs and market research functionalities, reflecting a significant evolution in the pharmaceutical industry.The expansion of EVERSANA's AI platform aims to create a more interconnected ecosystem for life sciences organizations, focusing on improving operational efficiency and accelerating execution. This initiative underscores a broader trend where pharmaceutical companies are transitioning from isolated AI exp
Press release cover image

Aug 20, 2026

Doceree Launches Care Sequence, Activating One Clinical Signal Across All Moments of Care, From the Waiting Room to the Pharmacy Counter

One verified clinical event, three stakeholders reached in order: the patient, the physician, and the pharmacist. SHORT HILLS, N.J., Aug. 20, 2026 /PRNewswire/ -- Doceree today launched Care Sequence, the first point-of-care offering to activate a brand across all moments of a patient encounter, from the waiting room to the pharmacy fill, on a single verified clinical signal. One coded clinical event triggers coordinated messaging to the patient, the physician, and the pharmacist, and the encoun
Press release cover image

Aug 20, 2026

EVERSANA Expands AI-Powered Commercialization Platform with New Capabilities Across Medical Affairs, Market Research and Commercial Operations

Expansion advances Company's vision for an AI-native, connected commercialization ecosystem to help life sciences organizations improve efficiency, accelerate execution and support better patient outcomes CHICAGO, Aug. 20, 2026 /PRNewswire/ -- EVERSANA, a leading provider of global commercialization services to the life sciences industry today announced expanded capabilities of their AI-powered commercialization platform.Originally launched to transform marketing agency operations, the platform
A pill bottle and prescription pad on a pharmacy counter in soft light

Aug 20, 2026

How Eli Lilly’s Global Vault CRM Rollout At Veeva Systems (VEEV) Has Changed Its Investment Story

Eli Lilly's recent decision to implement Veeva Vault CRM globally marks a significant shift in the pharmaceutical industry's adoption of AI-driven commercial tools. This move not only reflects a growing trend towards enhanced commercial workflows but also has substantial implications for Veeva Systems' investment narrative.The introduction of Veeva Vault CRM by Eli Lilly signals a commitment to leveraging advanced technologies to generate commercial evidence, which could reshape how pharmaceutic
A syringe and vial in a dimly lit lab setting

Aug 18, 2026

Enero's Orchard Launches 'AudienceIQ' AI Synthetic Patient & Clinician Panel For Pharma Marketing

Orchard has introduced AudienceIQ, a cutting-edge AI tool designed to create synthetic personas for patients and clinicians, aimed at revolutionizing pharmaceutical marketing.This innovative platform addresses a significant challenge in the pharmaceutical sector: the traditionally slow and costly nature of market research. By leveraging evidence-based personas, AudienceIQ allows marketing and medical teams to rapidly test concepts and materials, significantly reducing the time frame from months
A minimalist illustration of a pill bottle and a pill on a solid background.

Aug 18, 2026

Inside Eli Lilly's Global CRM Partnership With Veeva

Eli Lilly has strengthened its global partnership with Veeva Systems by adopting the Vault CRM System, a move aimed at enhancing the efficiency of its commercial operations and expanding patient access to innovative medicines. This collaboration underscores the pharmaceutical industry's increasing reliance on AI-driven solutions.The transition to Vault CRM marks a significant upgrade from Veeva's previous CRM platform, which was based on Salesforce. This shift is part of Veeva's strategy to prom
A minimalist illustration of a document with a checkmark, symbolizing efficient content review.

Aug 17, 2026

Streamline Content Review and Increase Reviewer Efficiency with Vault AI

Johnson & Johnson is leveraging Vault AI within its PromoMats platform to enhance the efficiency of content review processes, significantly minimizing manual tasks and repetitive quality checks.The initiative aims to streamline the review workflow, allowing reviewers to redirect their focus toward more strategic responsibilities. By automating mundane aspects of the review process, the company has taken a proactive approach to address the challenges associated with Medical, Legal, and Regulatory